Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The measurement of cyclic nucleotides by radioimmunoassay.

× No keyword cloud information.

9 in total

1. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.

Authors: Paul M McKie; Alessandro Cataliotti; Guido Boerrigter; Horng H Chen; S Jeson Sangaralingham; Fernando L Martin; Tomoko Ichiki; John C Burnett
Journal: Hypertension Date: 2010-10-25 Impact factor: 10.190

2. Effects of concanavalin A and a succinylated derivative on lymphocyte proliferation and cyclic nucleotide levels.

Authors: J W Hadden; E M Hadden; J R Sadlik; R G Coffey
Journal: Proc Natl Acad Sci U S A Date: 1976-05 Impact factor: 11.205

3. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.

Authors: J W Hadden; E M Hadden; R G Coffey
Journal: Infect Immun Date: 1976-02 Impact factor: 3.441

4. Intraocular extracellular cyclic nucleotide concentrations: the influence of vitreous surgery.

Authors: J Dalma-Weiszhauz; M Blumenkranz; M Hartzer; E Hernandez
Journal: Graefes Arch Clin Exp Ophthalmol Date: 1993-03 Impact factor: 3.117

5. Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.

Authors: Paul M McKie; John A Schirger; Sherry L Benike; Lynn K Harstad; Joshua P Slusser; David O Hodge; Margaret M Redfield; John C Burnett; Horng H Chen
Journal: Eur J Heart Fail Date: 2016-01-24 Impact factor: 15.534

6. A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.

Authors: Paul M McKie; Alessandro Cataliotti; Brenda K Huntley; Fernando L Martin; Timothy M Olson; John C Burnett
Journal: J Am Coll Cardiol Date: 2009-09-08 Impact factor: 24.094

7. CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.

Authors: Fernando L Martin; S Jeson Sangaralingham; Brenda K Huntley; Paul M McKie; Tomoko Ichiki; Horng H Chen; Josef Korinek; Gerald E Harders; John C Burnett
Journal: PLoS One Date: 2012-12-18 Impact factor: 3.240

8. Cardiorenal Effects of Long-Term Phosphodiesterase V Inhibition in Pre-Heart Failure.

Authors: Scott A Hubers; Siu-Hin Wan; Fadi W Adel; Sherry L Benike; John C Burnett; Christopher Scott; Horng H Chen
Journal: J Am Heart Assoc Date: 2022-01-08 Impact factor: 6.106

9. M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.

Authors: Paul M McKie; Alessandro Cataliotti; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal: J Am Heart Assoc Date: 2014-01-02 Impact factor: 5.501

9 in total